Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-25-002946

Chief Scientific Officer sold 4,000 shares at $12.51 ($50,040)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer Chief Scientific Officer 2025-01-06 Sale 10b5-1 −4,000 $12.51 $50,040 95,760 D: show line 1 in the form
Open-market sales · 4,000 sh · avg $12.51 · $50,040
Loading xslF345X05/ownership.xml…